Skip to content

Emerging epidemic of transmitted HIV drug resistance in low- and middle-income countries, with highest burden seen in MSM

Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs

Dolutegravir demonstrates good efficacy despite resistance

Slides from the presentation by Jim Demarest of ViiV Healthcare.

High rates of drug resistance among HIV-positive infants in South Africa

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

No significant risk of resistance if HIV infection occurs during use of Truvada PrEP

Average CD4 cell count at time HIV therapy was started increased among young people in New York City after 2009

Successful HIV drug resistance testing is possible when viral load is low

People who aren't taking HIV treatment are a major source of transmitted resistance in Swiss gay men